Attovia Therapeutics Stock Surges 24% After $289 Million IPO
Attovia Therapeutics stock jumps 24% in trading debut after $289 million biotech IPO, reflecting strong demand for new healthcare listings.
Attovia Therapeutics stock jumps 24% in trading debut after $289 million biotech IPO, reflecting strong demand for new healthcare listings.
Indian companies are paring back IPO ambitions as a sluggish stock market undermines investor demand, halting one of the world's busiest listing…
Biotech IPOs lead US markets in 2026, outpacing AI listings as healthcare innovation takes center stage over artificial intelligence.
ITG's $312.2 million US IPO, backed by Oaktree Capital, underscores strong institutional demand for new equity offerings and could provide a tailwind…
Singapore’s equity market braces for its largest IPO in years as data center operator AirTrunk nears a confidential filing, signaling a potential…
Mercedes-Benz and GIC’s backing of Momenta’s IPO underscores autonomous driving’s investment appeal and may ripple across Chinese tech stocks and German auto…
The Jio Platforms IPO filing, announced by Mukesh Ambani, sets the stage for a historic Indian stock market debut, drawing global investor…
China's securities regulator urged more IPOs from artificial intelligence and Hong Kong-listed companies, a move that could boost mainland exchange volumes and…
Poland’s Copper Valley proposal and Lumina Metals’ IPO pop highlight growing copper market momentum in Central Europe.
Chinese IPO demand eclipses SpaceX's $100 billion order book, driving Shanghai Composite gains as investors pivot to China's equity markets.
SpaceX, OpenAI, and Anthropic IPOs are overshadowing India's Jio, NSE, and Zepto offerings as global fund managers pivot to US mega-listings, draining…
Rising equity supply threatens to pressure the S&P 500 as companies rush to issue new shares amid elevated valuations.